{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:23:08Z","timestamp":1792959788045,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC015"],"award-info":[{"award-number":["SRC015"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ebiom.2026.106131","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:44:35Z","timestamp":1769845475000},"page":"106131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CFTR modulators partially restore the epithelial interferome in Aspergillus infection to improve clinical outcome"],"prefix":"10.1016","volume":"124","author":[{"given":"Sarah L.","family":"Laverty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen","family":"Felton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-4780","authenticated-orcid":false,"given":"Nicholas","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Armstrong-James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-520X","authenticated-orcid":false,"given":"Anand","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.ebiom.2026.106131_bib1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106131_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","article-title":"Cystic fibrosis","volume":"10","author":"Mall","year":"2024","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.ebiom.2026.106131_bib3","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jinf.2016.04.022","article-title":"Aspergillus infections in cystic fibrosis","volume":"72","author":"King","year":"2016","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106131_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098502","article-title":"Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis","volume":"9","author":"Armstead","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106131_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41579-023-00960-9","article-title":"The rapid emergence of antifungal-resistant human-pathogenic fungi","volume":"21","author":"Lockhart","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106131_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist","volume":"133","author":"Nichols","year":"2023","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106131_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2026.106131_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fcimb.2020.00321","article-title":"Dectin-1 promotes type I and III interferon expression to support optimal antifungal immunity in the lung","volume":"10","author":"Dutta","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106131_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan5357","article-title":"Type III interferon is a critical regulator of innate antifungal immunity","volume":"2","author":"Espinosa","year":"2017","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106131_bib10","article-title":"Cystic fibrosis lung transplant recipients have suppressed airway interferon responses during pseudomonas infection","volume":"1","author":"Dugger","year":"2020","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106131_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1165\/rcmb.2011-0080OC","article-title":"Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells","volume":"46","author":"Parker","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ebiom.2026.106131_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fimmu.2020.01327","article-title":"Rhinovirus infection drives complex host airway molecular responses in children with cystic fibrosis","volume":"11","author":"Ling","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106131_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2015.10.013","article-title":"Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection","volume":"15","author":"Sch\u00f6gler","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106131_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chom.2015.12.002","article-title":"Aspergillus cell wall melanin blocks LC3-associated phagocytosis to promote pathogenicity","volume":"19","author":"Akoumianaki","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2026.106131_bib15","article-title":"CXC chemokines in the pathogenesis of pulmonary disease and pharmacological relevance","volume":"2022","author":"Komolafe","year":"2022","journal-title":"Int J Inflamm"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106131_bib16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/thx.2006.060293","article-title":"COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis?","volume":"61","author":"Clayton","year":"2006","journal-title":"Thorax"},{"issue":"19","key":"10.1016\/j.ebiom.2026.106131_bib17","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1111\/bph.13249","article-title":"Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1","volume":"172","author":"Dauletbaev","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ebiom.2026.106131_bib18","article-title":"GM-CSF-mediated epithelial-immune cell crosstalk orchestrates pulmonary immunity to Aspergillus fumigatus","author":"Mills","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106131_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/17460913.3.2.145","article-title":"Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins","volume":"3","author":"Farrow","year":"2008","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ebiom.2026.106131_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156049","article-title":"IL-7: comprehensive review","volume":"160","author":"Winer","year":"2022","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106131_bib21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41385-018-0028-1","article-title":"The common \u03b3-chain cytokine IL-7 promotes immunopathogenesis during fungal asthma","volume":"11","author":"Reeder","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ebiom.2026.106131_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106047","article-title":"Hydroxycarboxylic acid receptor 3 and GPR84 - two metabolite-sensing G protein-coupled receptors with opposing functions in innate immune cells","volume":"176","author":"Peters","year":"2022","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106131_bib23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ppul.26261","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis","volume":"58","author":"Sheikh","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106131_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/cid\/ciac117","article-title":"The rapid reduction of infection-related visits and antibiotic use among people with cystic fibrosis after starting Elexacaftor-Tezacaftor-Ivacaftor","volume":"75","author":"Miller","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106131_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.202406-1128RL","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor markedly reduces Aspergillus fumigatus in cystic fibrosis","volume":"210","author":"Morgan","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106131_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106131_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11046-021-00541-5","article-title":"CF fungal disease in the age of CFTR modulators","volume":"186","author":"Bercusson","year":"2021","journal-title":"Mycopathologia"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106131_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.202310-1836OC","article-title":"Pharmacological improvement of cystic fibrosis transmembrane conductance regulator function rescues airway epithelial homeostasis and host defense in children with cystic fibrosis","volume":"209","author":"Loske","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106131_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.201106-1027OC","article-title":"Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation","volume":"185","author":"Chaudhary","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106131_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1183\/09031936.00096110","article-title":"Aspergillus fumigatus conidia induce interferon-\u03b2 signalling in respiratory epithelial cells","volume":"39","author":"Beisswenger","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106131_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004625","article-title":"IL-1\u03b1 signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge","volume":"11","author":"Caffrey","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106131_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/01902148.2011.569968","article-title":"Reduced surface toll-like receptor-4 expression and absent interferon-\u03b3-inducible protein-10 induction in cystic fibrosis airway cells","volume":"37","author":"John","year":"2011","journal-title":"Exp Lung Res"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106131_bib33","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.4049\/jimmunol.2000802","article-title":"MDA5 is an essential sensor of a pathogen-associated molecular pattern associated with vitality that is necessary for host resistance against Aspergillus fumigatus","volume":"205","author":"Wang","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2026.106131_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molimm.2022.11.014","article-title":"Overview of the anti-inflammatory function of the innate immune sensor NLRC3","volume":"153","author":"Zhao","year":"2023","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106131_bib35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4049\/jimmunol.1501811","article-title":"Human neutrophils use different mechanisms to kill Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects","volume":"196","author":"Gazendam","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106131_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/imr.12454","article-title":"How neutrophils kill fungi","volume":"273","author":"Gazendam","year":"2016","journal-title":"Immunol Rev"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106131_bib37","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.4049\/jimmunol.2100876","article-title":"IFN-\u03bb diminishes the severity of viral bronchiolitis in neonatal mice by limiting NADPH oxidase-induced PAD4-Independent NETosis","volume":"208","author":"Sebina","year":"2022","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106131_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for Covid-19","volume":"388","author":"Reis","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106131_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1513\/AnnalsATS.202312-1070OC","article-title":"The real-world effectiveness of antifungals in people with cystic fibrosis and aspergillus-positive cultures","volume":"22","author":"Faerber","year":"2025","journal-title":"Ann Am Thorac Soc"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:42:50Z","timestamp":1775097770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426000125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"alternative-id":["S2352396426000125"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106131","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CFTR modulators partially restore the epithelial interferome in Aspergillus infection to improve clinical outcome","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106131"}}